Results 221 to 230 of about 4,684,794 (400)

Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.

American Journal of Medicine, 2016
M. Barra, J. Fanikos, J. Connors, K. Sylvester, G. Piazza, S. Goldhaber   +5 more
semanticscholar   +1 more source

Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries

Arthritis &Rheumatology, EarlyView.
Objective Our objective was to assess the incidence of major adverse cardiovascular events (MACEs) in patients with rheumatoid arthritis (RA) treated with JAK inhibitors (JAKi), tumor necrosis factor inhibitors (TNFi), or biologic disease‐modifying antirheumatic drugs with other modes of action (bDMARD‐OMA) in a multicountry, real‐world population ...
Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling, Denis Choquette, Catalin Codreanu, Daniela Di Giuseppe, Irini Flouri, Doreen Huschek, Kimme L. Hyrich, Florenzo Iannone, Tore K. Kvien, Burkhard F. Leeb, Dan Nordström, Lucia Otero‐Varela, Karel Pavelka, Manuel Pombo‐Suarez, Ana Rodrigues, Ziga Rotar, Prodromos Sidiropoulos, Sella A. Provan, Anja Strangfeld, Trokovic Nina, Jakub Zavada, Lianne Kearsley‐Fleet, Delphine S. Courvoisier, Axel Finckh, Kim Lauper   +28 more
wiley   +1 more source

Clinical outcomes and hemorrhagic or thromboembolic risks in decompressive craniectomy for patients taking antiplatelet or anticoagulant therapy. [PDF]

Neurosurg Rev
Scerrati A, Scanferla G, Sgarbanti L, Mantovani G, Angelini C, Flacco ME, Maugeri R, Bonosi L, Iacopino DG, Tumbiolo S, Adorno A, Brunasso L, Lofrese G, Rosetti V, Tosatto L, Somma T, Cavallo LM, Lombardi S, Sturiale CL, Signorelli F, Auricchio AM, Menna G, Ricciardi L, Montemurro N, Raneri F, Rustemi O, Zambon G, Cavallo MA, De Bonis P.   +28 more
europepmc   +1 more source

Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities

Arthritis &Rheumatology, EarlyView.
Antiphospholipid syndrome (APS) is an autoimmune thromboinflammatory disease characterized by vascular thrombosis, pregnancy morbidity, and other manifestations driven by antiphospholipid autoantibodies. In this review, we present a clinical case that illustrates some diagnostic and therapeutic challenges in managing severe, relapsing APS ...
Thalia G. Newman, Jason S. Knight
wiley   +1 more source

Perirenal Hematoma: A Rare Complication of Anticoagulant Therapy. [PDF]

Cureus, 2023
Silva F, Moutinho J, Nascimento J, Vasconcelos T, Simões IG.   +4 more
europepmc   +1 more source

Adrenal Hemorrhage During Anticoagulant Therapy

, 1974
C Danese, ROBERT M. VIOLA
openalex   +2 more sources

The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism [PDF]

, 1997
Sam Schulman, S. Granqvist, Margareta Holmström, Anders Carlsson, Per Lindmarker, Peter Nicol, S.‐G. Eklund, Sune Nordlander, Gerd Lärfars, Barbro Leijd, Olle Linder, Enno Loogna, Hans Walter, Stanka Viering, Martin Hjorth, Jonas Boberg   +15 more
openalex   +1 more source

New concepts for anticoagulant therapy in persons with hemophilia.

Blood, 2016
R. Schutgens, J. F. van der Heijden, E. Mauser-Bunschoten, P. Mannucci   +3 more
semanticscholar   +1 more source

Prognostic value of lupus anticoagulant and anti‐β2 glycoprotein I antibody in adverse pregnancy outcomes.

Arthritis &Rheumatology, Accepted Article.
Objective International criteria for antiphospholipid syndrome (APS) include lupus anticoagulant (LA), anticardiolipin (aCL) immunoglobulin (Ig) G and IgM, and anti‐β2‐glycoprotein I (β2GPI) IgG and IgM. However, evidence supporting their prognostic value or treatment efficacy in improving live birth rates is limited.
Megumi Nonobe, Takahiro Otani, Hiroyuki Yoshihara, Shinobu Goto, Tamao Kitaori, Naomi Nishikawa, Yuichiro Fujieda, Tatsuya Atsumi, Mayumi Sugiura‐Ogasawara   +8 more
wiley   +1 more source

Evaluation of Chitosan-Based Axiostat as Hemostatic Dressing for Endovascular Procedures in Patients with Leriche Syndrome on Anticoagulant Therapy. [PDF]

Pharmaceuticals (Basel)
Perri P, Curcio F, De Luca M, Piro P, Trombino S, Cassano R.   +5 more
europepmc   +1 more source